A retrospective study investigating efficacy of posaconazole as a primary prophylaxis in patients having breakthrough invasive fungal disease.
Phase of Trial: Phase IV
Latest Information Update: 31 Dec 2015
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Fusariosis; Mycoses
- Focus Therapeutic Use
- 31 Dec 2015 New trial record